The advertisement promotes ADSTILADRIN as a treatment option for adults with high-risk non-muscle-invasive bladder cancer (NMIBC) when BCG therapy is ineffective.
Creative Information
| CID: | 58751d7d-6a76-4578-b95b-ef01d86edfc5 |
| CRID: | 25_mfxvv000 |
| Domain: | ferring.com |
| Seat: | TTD |
| Size: | 160x600 |
| Bid: | $0.68 |
| Timestamp: | 10/31/2025, 7:02:36 PM |
| Declared IAB Categories: |
Analysis
5 succeeded(100% complete)
| Task | Status | Last Updated | Duration | Actions |
|---|---|---|---|---|
| ad_analysis | success | 10/31/2025, 8:51:29 PM | 5.92s | |
| adomain_analysis | success | 10/31/2025, 9:32:35 PM | 5.10s | |
| adomain_capture | success | 10/31/2025, 9:32:30 PM | 0.19s | |
| ad_render | success | 10/31/2025, 8:51:23 PM | 30.76s | |
| brand_mapping | success | 10/31/2025, 7:02:36 PM | 0.12s | |
Analysis Results
Ad Format: banner
Brands: Ferring
Sensitive:Misleading Health ClaimsUnverified Medical TreatmentsPharmaceutical Products
Quality:Adomain not match landing page domain
| Size: | 160x600 | ||||||||||||||||||||||
| Data Transferred: | 706.00 KB | ||||||||||||||||||||||
| Render Time: | 7.83 Seconds | ||||||||||||||||||||||
| Creative Inferred IAB Categories: |
| ||||||||||||||||||||||
| Creative Inferred IAB Ad Products: |
| ||||||||||||||||||||||
| Domain Inferred IAB Categories: |
| ||||||||||||||||||||||
| Domain Inferred IAB Ad Products: |
| ||||||||||||||||||||||
| Landing Page: | |||||||||||||||||||||||
| Total Ad Size: | 725.22 KB | ||||||||||||||||||||||
| Requests Made: |
|
Advertiser Domain

Ad Preview
Landing Page

Creatives


